Cellectis To Present Pre-Clinical Data On TALEN-Edited Smart CAR T-Cells Supporting Improved Solid Tumor Targeting At The Society For Immunotherapy Of Cancer's 37th Annual Meeting November 10
Cellectis To Present Pre-Clinical Data On TALEN-Edited Smart CAR T-Cells Supporting Improved Solid Tumor Targeting At The Society For Immunotherapy Of Cancer's 37th Annual Meeting November 10
Cellectis will present a poster on TALEN-edited smart CAR T-cells targeting MUC1- expressing solid tumors. MUC1 is a tumor-associated antigen that is overexpressed in triple-negative breast cancer (TNBC) and other solid tumor malignancies.NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that pre-clinical data on TALEN-edited smart CAR T-cells to overcome key challenges of targeting solid tumors, will be presented at the Society for Immunotherapy of Cancer's 37th Annual Meeting (SITC 2022), to be held in Boston, M.A. and virtually on November 8-12, 2022.
纽约，2022年10月5日(环球网)--Cellectis(公司)(纳斯达克：CLLS)，一家临床阶段的生物技术公司，利用其开创性的基因编辑平台开发拯救生命的细胞和基因疗法，今天宣布关于TALEN的临床前数据-编辑的智能汽车T细胞，以克服针对实体肿瘤的关键挑战，将在将于2022年11月8日至12日在马萨诸塞州波士顿举行的第37届癌症免疫治疗年会(SITC 2022)上发表。
Presentations include:
演示文稿包括：
Poster presentation:
海报演示文稿：
Cellectis will present a poster on TALEN-edited smart CAR T-cells targeting MUC1- expressing solid tumors. MUC1 is a tumor-associated antigen that is overexpressed in triple-negative breast cancer (TNBC) and other solid tumor malignancies.
Cellectis将在TALEN编辑的智能汽车T细胞上展示一张海报，目标是表达MUC1的实体肿瘤。MUC1是一种肿瘤相关抗原，在三阴性乳腺癌(TNBC)和其他实体肿瘤中过度表达。
Title: Multi-armored allogeneic MUC-1 CAR T-cells efficiently control triple negative breast cancer tumor growth
Poster Number: 217
Presenter: Piril, Erler Ph.D., Scientist II, Immuno-Oncology, Cellectis
Date/Time: Thursday, November 10th, posters will be on display from 9:00 AM- 9:00 PM, Hall C
标题：多装甲同种异体MUC-1 CAR T细胞有效控制三重负乳腺癌生长
海报编号: 217
主讲人：皮里尔，Erler博士，二级科学家，免疫肿瘤学，盲肠炎
日期/时间：11月10日星期四，C厅上午9：00至晚上9：00张贴海报
Poster presentation:
海报演示文稿：
Cellectis will present a poster on innovative T-cell engineering strategies designed to increase the activity of CAR T-cells for solid tumors while mitigating toxicity risk.
Cellectis将展示一张关于创新T细胞工程战略的海报，该战略旨在提高CAR T细胞对实体肿瘤的活性，同时降低毒性风险。
Title: TALEN-edited smart CAR T-cells leverage solid tumor microenvironment for specific and effective immunotherapy
Poster Number: 325
Presenter: Shipra Das Ph.D., Senior Scientist & Team Leader Immuno-Oncology, Cellectis
Date/Time: Thursday, November 10th, posters will be on display from 9:00 AM- 9:00 PM, Hall C
标题：塔伦-编辑的智能汽车T细胞利用固体肿瘤微环境进行特异有效的免疫治疗
海报编号: 325
主讲人：Shipra Das博士，Cellectis高级科学家兼免疫肿瘤学团队负责人
日期/时间：11月10日星期四，C厅上午9：00至晚上9：00张贴海报
Full text of the abstracts will be released on the SITC website at 8:00 a.m. EST on November 7, 2022.
摘要全文将于上午8点在SITC网站上发布。美国东部时间2022年11月7日。